GEHC vs. RMD: GE HealthCare vs. ResMed Stock Comparison

Company Profile

GE HealthCare (GEHC) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

ResMed (RMD) has more than two decades of public-market history since June 2, 1995, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both GE HealthCare (GEHC) at 20.01% and ResMed (RMD) at 26.40% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both GE HealthCare (GEHC) at 9.95% and ResMed (RMD) at 27.79% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both GE HealthCare (GEHC) at 15.33% and ResMed (RMD) at 34.82% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both GE HealthCare (GEHC) at 4.84% and ResMed (RMD) at 9.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Only one side can be read here: GE HealthCare (GEHC) reports EPS growth of 4.84%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.

Growth Metrics

Financial Strength

ResMed (RMD) at 2.65 keeps current ratio within its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for GEHC.

ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while GE HealthCare (GEHC) at 0.88 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Both GE HealthCare (GEHC) at 0.17% and ResMed (RMD) at 1.03% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both GE HealthCare (GEHC) at 2.96% and ResMed (RMD) at 22.40% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while ResMed (RMD) at 21.43 is closer to its industry’s usual earnings multiple — a discount for GEHC, though growth and earnings durability still matter.

GE HealthCare (GEHC) at 1.72 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.

On P/B ratio, both GE HealthCare (GEHC) at 3.21 and ResMed (RMD) at 5.56 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics